Michael Kauffman, Director at Karyopharm Therapeutics Inc. (KPTI), sold 36,334 shares at $12.12 ($440K) on 2022-02-17, disclosed to the SEC on 2022-02-22.
Open-market sale of $440k KPTI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.12 | 9,079 | $110K | 25.0% |
| 2 | $12.12 | 9,079 | $110K | 25.0% |
| 3 | $12.12 | 9,088 | $110K | 25.0% |
| 4 | $12.12 | 9,088 | $110K | 25.0% |
| Total | $12.12 avg | 36,334 | $440K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |
| KZR | SELL | 2022-01-05 | $82K | — | Filing → |